Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ivermectin-exposed P.univalens: tissue transcriptomics and gene coexpression networks

ABSTRACT: Gene co-expression network analysis reveal core responsive genes in Parascaris univalens tissues following ivermectin exposure

PROVIDER: PRJEB70467 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR12318730_1.fastq.gz	Fastqsanger.gz
	ERR12318730_2.fastq.gz	Fastqsanger.gz
	ERR12318731_1.fastq.gz	Fastqsanger.gz
	ERR12318731_2.fastq.gz	Fastqsanger.gz
	ERR12318732_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 58

Similar Datasets

Project description:Parascaris univalens ivermectin response

| PRJNA680223 | ENA

Ivermectin-exposed C.elegans (N2) transcriptomics

Project description:Ivermectin-exposed C.elegans (N2) transcriptomics

| PRJEB70616 | ENA

Ivermectin-exposed C.elegans (N2) transcriptomics

Project description:Transcriptomics of Ivermectin Response in Caenorhabditis elegans: integrating Abamectin Quantitative Trait Loci and Comparison to the Ivermectin-Exposed DA1316 Strain

| PRJEB59331 | ENA

Expression data from Caenorhabditis elegans exposed to ivermectin

2011-04-01 | GSE22660 | GEO

Expression data from Caenorhabditis elegans exposed to ivermectin

Project description:We have investigated the transcriptomic response of the model nematode Caenorhabditis elegans to ivermectin (IVM); an important anthelmintic for human and animal parasite control. The transcriptomic response of the mutant strain DA1316 avr-14(ad1302); avr-15(ad1250); glc-1(pk54), which is highly resistant to ivermectin due to null mutations in three glutamate-gated chloride channel subunits, was examined. Despite the resistant nature of this strain, pharyngeal pumping rate was decreased following 4 hrs exposure to 100ng/ml and 1?g/ml ivermectin resulting in significant change in the expression level of genes associated with a fasting response. Matched cultures of synchronised C. elegans were grown to L4 stage on standard NGM plates with an OP50 bacterial lawn. The nematodes were then transferred to NGM plates containing 100ng/ml ivermectin, 1?g/ml ivermectin, or DMSO excipient only (control) for 4 hours. RNA was extracted from five biological replicates including controls for both the 100ng/ml ivermectin and 1?g/ml ivermectin experiments and hybridised to Affymetrix arrays.

2011-04-01 | E-GEOD-22660 | biostudies-arrayexpress

Parascaris univalens

Project description:Parascaris univalens microbiome

| PRJNA851370 | ENA

Parascaris univalens

Project description:Parascaris univalens overview

| PRJNA386832 | ENA

Parascaris univalens

Project description:Parascaris univalens 16S rRNA microbiome

| PRJNA851371 | ENA

Transcriptional responses in Parascaris univalens

Project description:Transcriptional responses in Parascaris univalens after in vitro exposure to ivermectin, pyrantel citrate and thiabendazole

| PRJEB37010 | ENA

Ivermectin inhibits the growth of esophageal squamous cell carcinoma by activating ATF4-mediated endoplasmic reticulum stress-autophagy pathway

Project description:Esophageal squamous cell carcinoma (ESCC) is one of the most common form of malignancies in the world. However, there is currently a lack of effective chemotherapeutic drugs for ESCC, and it is urgent to develop new and safe drugs for this disease. Ivermectin is a broad-spectrum antiparasitic drug with demonstrable antitumor activity. However, the precise cellular and molecular mechanisms of ivermectin in cancers growth inhibition remain unclear. In this study, we report a role of ivermectin in ESCC suppression by activating the endoplasmic reticulum (ER) stress and autophagy. In transcriptome analysis, we found that ATF4 and DDIT3 are involved in ER stress activation by ivermectin. Moreover, ivermectin treatment suppressed the growth of ESCC xenograft tumors in nude mice. Taken together, our results identify the antitumor molecular basis of ivermectin targeting the ER stress-autophagy pathway and suggest that ivermectin is a potential drug for the treatment of ESCC.

2024-12-18 | GSE201404 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data